mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.5 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.5 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.5 |